Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2026 Earnings Call Transcript May 7, 2026
Collegium Pharmaceutical, Inc. beats earnings expectations. Reported EPS is $1.76, expectations were $1.52.
Operator: Greetings, and welcome to the Collegium Pharmaceutical’s First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded. I’ll now turn the call over to Ian Karp, Head of Investor Relations at Collegium. Thank you. You may now...
